Double Medical Technology Inc. (SHE:002901)
35.74
+0.48 (1.36%)
Apr 2, 2025, 2:45 PM CST
Double Medical Technology Revenue
Double Medical Technology had revenue of 565.13M CNY in the quarter ending September 30, 2024, with 50.38% growth. This brings the company's revenue in the last twelve months to 1.94B, up 46.22% year-over-year. In the year 2023, Double Medical Technology had annual revenue of 1.53B with 6.90% growth.
Revenue (ttm)
1.94B
Revenue Growth
+46.22%
P/S Ratio
7.79
Revenue / Employee
480.27K
Employees
4,033
Market Cap
14.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.53B | 99.02M | 6.90% |
Dec 31, 2022 | 1.43B | -560.23M | -28.09% |
Jan 1, 2022 | 1.99B | 407.47M | 25.68% |
Dec 31, 2020 | 1.59B | 329.54M | 26.21% |
Dec 31, 2019 | 1.26B | 484.85M | 62.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Sichuan Biokin Pharmaceutical | 5.82B |